Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema

Abstract The aim of this work was to investigate the changes in aqueous humor cytokine levels after intravitreal injection of aflibercept in diabetic macular edema (DME) and to evaluate the relationship between cytokines modifications and central macular thickness (CMT) and retinal/choroidal vascula...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rodolfo Mastropasqua, Rossella D’Aloisio, Marta Di Nicola, Giuseppe Di Martino, Alessia Lamolinara, Luca Di Antonio, Daniele Tognetto, Lisa Toto
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/595803eecb934c5cbfe82fd32fce1dae
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:595803eecb934c5cbfe82fd32fce1dae
record_format dspace
spelling oai:doaj.org-article:595803eecb934c5cbfe82fd32fce1dae2021-12-02T15:07:52ZRelationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema10.1038/s41598-018-35036-92045-2322https://doaj.org/article/595803eecb934c5cbfe82fd32fce1dae2018-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-35036-9https://doaj.org/toc/2045-2322Abstract The aim of this work was to investigate the changes in aqueous humor cytokine levels after intravitreal injection of aflibercept in diabetic macular edema (DME) and to evaluate the relationship between cytokines modifications and central macular thickness (CMT) and retinal/choroidal vascular changes using structural and functional optical coherence tomography (OCT). Aqueous concentrations of 38 cytokines were measured via multiplex bead assay. In addition, spectral domain OCT and OCT angiography with SSADA software (XR Avanti® AngioVue) were performed at baseline and after intravitreal injections. VEGF, IL-6, IL-5, IL-1β, Eotaxin, GRO, IL-12p40, IL-12p70, IL-1RA, Flt-3L and IP-10 showed a statistically significant decrease through the follow-up (p < 0.05; p < 0.001), while Fraktalkine and GM-CSF significantly increased (p < 0.05). Best corrected visual acuity significantly increased and CMT significantly decreased during follow-up (p < 0.001 and p = 0.013). Superficial capillary plexus and deep capillary plexus density significantly increased (p < 0.001 and p = 0.014). A positive relation was found between GRO, VEGF, Fraktalkine, IP-10, IL-12p70 aqueous humor levels and CMT (p < 0.05; p < 0.001). Aflibercept is a primary anti-VEGF treatment producing a decrease of DME due to the reduction of vascular permeability, nevertheless other inflammatory cytokines showed modification after aflibercept intravitreal injections probably related to edema modification or to an interaction of aflibercept with other inflammatory cytokines.Rodolfo MastropasquaRossella D’AloisioMarta Di NicolaGiuseppe Di MartinoAlessia LamolinaraLuca Di AntonioDaniele TognettoLisa TotoNature PortfolioarticleAfliberceptDiabetic Macular Edema (DME)Central Macular Thickness (CMT)Vascular Endothelial Growth Factor (VEGF)Superficial Capillary Plexus (SCP)MedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
institution DOAJ
collection DOAJ
language EN
topic Aflibercept
Diabetic Macular Edema (DME)
Central Macular Thickness (CMT)
Vascular Endothelial Growth Factor (VEGF)
Superficial Capillary Plexus (SCP)
Medicine
R
Science
Q
spellingShingle Aflibercept
Diabetic Macular Edema (DME)
Central Macular Thickness (CMT)
Vascular Endothelial Growth Factor (VEGF)
Superficial Capillary Plexus (SCP)
Medicine
R
Science
Q
Rodolfo Mastropasqua
Rossella D’Aloisio
Marta Di Nicola
Giuseppe Di Martino
Alessia Lamolinara
Luca Di Antonio
Daniele Tognetto
Lisa Toto
Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
description Abstract The aim of this work was to investigate the changes in aqueous humor cytokine levels after intravitreal injection of aflibercept in diabetic macular edema (DME) and to evaluate the relationship between cytokines modifications and central macular thickness (CMT) and retinal/choroidal vascular changes using structural and functional optical coherence tomography (OCT). Aqueous concentrations of 38 cytokines were measured via multiplex bead assay. In addition, spectral domain OCT and OCT angiography with SSADA software (XR Avanti® AngioVue) were performed at baseline and after intravitreal injections. VEGF, IL-6, IL-5, IL-1β, Eotaxin, GRO, IL-12p40, IL-12p70, IL-1RA, Flt-3L and IP-10 showed a statistically significant decrease through the follow-up (p < 0.05; p < 0.001), while Fraktalkine and GM-CSF significantly increased (p < 0.05). Best corrected visual acuity significantly increased and CMT significantly decreased during follow-up (p < 0.001 and p = 0.013). Superficial capillary plexus and deep capillary plexus density significantly increased (p < 0.001 and p = 0.014). A positive relation was found between GRO, VEGF, Fraktalkine, IP-10, IL-12p70 aqueous humor levels and CMT (p < 0.05; p < 0.001). Aflibercept is a primary anti-VEGF treatment producing a decrease of DME due to the reduction of vascular permeability, nevertheless other inflammatory cytokines showed modification after aflibercept intravitreal injections probably related to edema modification or to an interaction of aflibercept with other inflammatory cytokines.
format article
author Rodolfo Mastropasqua
Rossella D’Aloisio
Marta Di Nicola
Giuseppe Di Martino
Alessia Lamolinara
Luca Di Antonio
Daniele Tognetto
Lisa Toto
author_facet Rodolfo Mastropasqua
Rossella D’Aloisio
Marta Di Nicola
Giuseppe Di Martino
Alessia Lamolinara
Luca Di Antonio
Daniele Tognetto
Lisa Toto
author_sort Rodolfo Mastropasqua
title Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
title_short Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
title_full Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
title_fullStr Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
title_full_unstemmed Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
title_sort relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/595803eecb934c5cbfe82fd32fce1dae
work_keys_str_mv AT rodolfomastropasqua relationshipbetweenaqueoushumorcytokinelevelchangesandretinalvascularchangesafterintravitrealafliberceptfordiabeticmacularedema
AT rosselladaloisio relationshipbetweenaqueoushumorcytokinelevelchangesandretinalvascularchangesafterintravitrealafliberceptfordiabeticmacularedema
AT martadinicola relationshipbetweenaqueoushumorcytokinelevelchangesandretinalvascularchangesafterintravitrealafliberceptfordiabeticmacularedema
AT giuseppedimartino relationshipbetweenaqueoushumorcytokinelevelchangesandretinalvascularchangesafterintravitrealafliberceptfordiabeticmacularedema
AT alessialamolinara relationshipbetweenaqueoushumorcytokinelevelchangesandretinalvascularchangesafterintravitrealafliberceptfordiabeticmacularedema
AT lucadiantonio relationshipbetweenaqueoushumorcytokinelevelchangesandretinalvascularchangesafterintravitrealafliberceptfordiabeticmacularedema
AT danieletognetto relationshipbetweenaqueoushumorcytokinelevelchangesandretinalvascularchangesafterintravitrealafliberceptfordiabeticmacularedema
AT lisatoto relationshipbetweenaqueoushumorcytokinelevelchangesandretinalvascularchangesafterintravitrealafliberceptfordiabeticmacularedema
_version_ 1718388386600845312